InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by NEUMANN CLARKE. Insider active across 3 companies, notably Progenity, INC.. In total, 9 disclosures have been recorded. The latest transaction was disclosed on 15 May 2022 — Retenue fiscale. Regulator: SEC (Form 4). All data is openly available.
Declarations9 total
€5,9898,305 shares@ €0.72110.0000% mcap100.0% of flow
Common Stock
SEC:0000899243-22-018432:0·
0184,843 shares0
Common Stock
SEC:0000899243-22-015060:0·
€2,8841,716 shares@ €1.680514.5% of flow
Common Stock
SEC:0000899243-22-006783:0·
€2,281752 shares@ €3.032826.8% of flow
Common Stock
SEC:0000899243-21-045047·
€2,281752 shares@ €3.032811.5% of flow
Common Stock
SEC:0000899243-21-045047:0·
€3,2882,336 shares@ €1.407438.6% of flow
Common Stock
SEC:0000899243-21-033256·
€3,2882,336 shares@ €1.407416.5% of flow
Common Stock
SEC:0000899243-21-033256:0·
€2,9411,505 shares@ €1.954134.6% of flow
Common Stock
SEC:0000899243-21-019674·
€2,9411,505 shares@ €1.954114.8% of flow
Common Stock
SEC:0000899243-21-019674:0·
9 of 9 declarations
About NEUMANN CLARKE
Clarke Neumann is a director at Progenity, Inc. and Biora Therapeutics, Inc.
